Alnylam Pharmaceuticals

Jeordan Legon

Director, Digital Center of Excellence
Alnylam Pharmaceuticals

Over the course of more than 25 years—which includes leadership positions at Harvard Medical School, Novartis, Roche, Genentech, and most recently, Alnylam—Jeordan Legon has helped healthcare companies think differently about their marketing strategy and healthcare digital ecosystems with industry-first digital projects.

Since joining Alnylam in 2017, Jeordan has led the digital marketing initiatives to support the launch of the company’s first FDA-approved product, Onpattro, and designed digital strategies to prepare the market for two more products in development, givosiran and lumasiran. By the end of 2018, 18 websites were launched to support Onpattro, an extraordinary 39 million ad impressions were served for Onpattro and hereditary (hATTR) amyloidosis awareness, and more than 500,000 total clicks were made on paid search and media ads. Jeordan also launched, the company’s first-ever online/offline support program that assists patients getting started on Onpattro by introducing them to their actual case managers through the use of geolocation technology.

And yet, Jeordan has still done more at Alnylam by championing an enterprise-wide architecture that supports global marketing communications in more than seven languages and 195 countries to ensure Alnylam has the ability to capture interactions with all stakeholders while properly managing GDPR and consent management worldwide.

Jeordan Legon’s Session(s)

9:20 am–10:20 am
Building Your Brand's Digital Ecosystem - What It Takes to Fully Embed Digital Into your Core Business Strategy

Copyright © 2020 Lincoln Health Network | Terms and Conditions | Privacy Policy